Mode of Action- FENFURO

It is known that in a healthy human body each cell membrane normally contains some 20000 active insulin receptors whereas in an insulin resistance patient cell membrane has around 5000 active insulin receptors, causing excess free floating insulin and glucose.

• FENFURO^TM is dual action insulin sensitizer.
• In presence of high fiber Furostanolic Saponins cells are more sensitive to insulin & an increase in number of insulin receptor sites occurs which are responsive to insulin to stimulate the cells ability to burn glucose ( i.e. newer insulin receptors with definite insulin sensitizing activity due to specific effects on the islets of langerhans in the pancreas)
• High fiber Furostanolic Saponins delays the rate of gastric emptying and slow carbohydrate absorption resulting in reducing insulin requirements. THEREBY BRINGS EUGLYCEMIC EFFECTS.
• Furostanolic Saponins also increase peripheral utilization of insulin & insulin sensitizing activity THEREBY BRINGS DOWN THE HYPERINSULLINAMEA the root cause of DIABETIC COMPLICATIONS
• High fiber Furostanolic Saponins increases viscosity of the digesta thereby inhibiting cholesterol absorption from small intestine and also the inhibition of bile acid re-absorption from the terminal ileum. Thus there is decrease in VLDL, LDL & Triglycerides levels.

Technology breakthrough in Diabetes Management

Novel & Innovated process, U.S. Patent Granted